NeurAxis Past Earnings Performance
Past criteria checks 0/6
NeurAxis's earnings have been declining at an average annual rate of -39.9%, while the Medical Equipment industry saw earnings growing at 11.3% annually. Revenues have been growing at an average rate of 6.2% per year.
Key information
-39.9%
Earnings growth rate
-27.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 6.2% |
| Return on equity | n/a |
| Net Margin | -594.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How NeurAxis makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2 | -15 | 9 | 0 |
| 30 Sep 23 | 3 | -10 | 8 | 0 |
| 30 Jun 23 | 3 | -7 | 6 | 0 |
| 31 Mar 23 | 3 | -7 | 6 | 0 |
| 31 Dec 22 | 3 | -6 | 6 | 0 |
| 30 Sep 22 | 3 | -6 | 5 | 0 |
| 31 Dec 21 | 3 | -4 | 5 | 0 |
| 31 Dec 20 | 2 | -4 | 5 | 0 |
Quality Earnings: NRXS is currently unprofitable.
Growing Profit Margin: NRXS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if NRXS's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare NRXS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NRXS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.6%).
Return on Equity
High ROE: NRXS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.